Author(s):
G. Haritha, Vijey Aanandhi M, P. Shanmugasundaram
Email(s):
director.sps@velsuniv.ac.in
DOI:
10.52711/0974-360X.2021.00365 
Address:
G. Haritha1, Vijey Aanandhi M2, P. Shanmugasundaram3*
1Research Scholar, Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India.
2Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India.
3Director, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2021
ABSTRACT:
Present investigation is based upon a new method development and validation for the simultaneous estimation of drugs comes under the classification of anti-hypertensive and anti-diabetic. For the proposed method metformin, ivabradine, metoprolol and ertugliflozin drugs were selected. The chromatographic separation was achieved by using mobile phase 0.01N potassium dihydrogen ortho phosphate buffer and acetonitrile (50:50) ratio and stationary phase of kromasil C18(250×4.6mm, 5µm) column. The retention times for metformin, ivabradine, metoprolol and ertugliflozin were found to be 2.560min, 3.116 min, 3.473 min and 5.196 min respectively. The developed method shows that all the drugs were clearly separated among each other with the system suitability. The developed method was further validated as per ICH guidelines Q2R1. It was found the method was accurate, presice with good linearity. Hence this method can be used for the routine analysis of these drugs in biological sample.
Cite this article:
G. Haritha, Vijey Aanandhi M, P. Shanmugasundaram. Novel Method Development for Metformin, Ivabradine, Metoprolol and Ertugliflozin and its Validation in API and Pharmaceutical Dosage Form by RPHPLC Method. Research Journal of Pharmacy and Technology. 2021; 14(4):2055-1. doi: 10.52711/0974-360X.2021.00365
Cite(Electronic):
G. Haritha, Vijey Aanandhi M, P. Shanmugasundaram. Novel Method Development for Metformin, Ivabradine, Metoprolol and Ertugliflozin and its Validation in API and Pharmaceutical Dosage Form by RPHPLC Method. Research Journal of Pharmacy and Technology. 2021; 14(4):2055-1. doi: 10.52711/0974-360X.2021.00365 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-41
REFERENCES:
1. Available at https://www.who.int/news-room/facts-in-pictures/detail/diabetes,21st February,2018.
2. Diabetes Care. 2004; 27(5): 1047-1053. Available at https://doi.org/10.2337/diacare.27.5.1047
3. Government survey found 11.8% prevalence of diabetes in India, 2 min read. 2019; IST Neetu Chandra Sharma. Available at https://www.livemint.com/science/health/government-survey-found-11-8-prevalence-of-diabetes-in-india-11570702665713.html.
4. Available at https://www.dailyexcelsior.com/dr-rampal-delivers-lecture-on-diabetes-in-up/
5. Available at https://www.who.int/news-room/fact-sheets/detail/hypertension
6. Brenda B. Spriggs. 2019; Availble at https://www.medicalnewstoday.com/articles/150109.php
7. Anchala, Raghupathy, Kannuri, Nanda, Pant, Hira, Khan, Hassan, Franco, Oscar, Angelantonio, Emanuele, Dorairaj and Prabhakaran. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of Hypertension. 2014; 32(6): 1170–1177.
8. Smita S. Swami, Sanjay C. Swami, Vinayak W. Patil, Anuradha M. Kanhere. hypertension and diabetes in india: a review. International Journal of Clinical Biochemistry and Research. 2015;2(1):54-58.
9. Rajeev Gupta, Krishna K Sharma, Sailesh Lodha, Sunil Gupta, Anand S Meenawat, Anuj Maheshwari, Bhupendra N Mahanta, Dinesh C Sharma, Arthur J Asirvatham, Shreya Gupta and Surendra K Sharma. High-Performance Liquid Chromatography (HPLC) method for the simultaneous estimation of metformin hydrochloride and ertugliflozin in pharmaceutical formulation. Journal of the Association of Physicians of India. 2018; 66.
10. Tong-Yuan Tai, Lee-Ming Chuang, Chien-Jen Chen and Boniface J Lin. Link Between Hypertension and Diabetes Mellitus Epidemiological Study of Chinese Adults in Taiwan. Diabetes Care. 1991; 14 (11) 1013-1020.
11. David M. Maahs, Gregory L. Kinney, Paul Wadwa, Janet K. Snell-Bergeon, Dana Dabelea, John Hokanson, James Ehrlich, Satish Garg, Robert H. Eckel and Marian J. Rewers. Hypertension Prevalence, Awareness, Treatment, and Control in an Adult Type 1 Diabetes Population and a Comparable General Population.
12. Treatment of Hypertension in Adults With Diabetes. Diabetes Care. 2007;26(1):80-82.
13. Available at Drug bank, Metformin, https://www.drugbank.ca/drugs/DB00331.
14. Available at Drug bank, Ivabradine, https://www.drugbank.ca/drugs/DB09083.
15. Available at https://www.drugbank.ca/drugs/DB00264.
16. Available at https://www.drugbank.ca/drugs/DB11827.
by